Feed DVA
DV

DaVita

DVA · NYSE

$181.48 +0.08% (+$0.15)
1M +1.33%
Market Cap $11.6B
P/E Ratio 13.74x
Div. Yield -
ROE -

Bulios Fair Price

$210.5

16.0% upside

Trenutna cena

$181.48

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica DVA trenutno podcenjena glede na svojo tržno ceno. Kako deluje?

Odkleni pošteno ceno

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Strong
7/9
Valuation
95 /100
Cheap
P/E 13.74x
EV/EBITDA 7.88x
P/S 0.83x
Growth
66 /100
Stable
EPS growth 18.54%
Rev. growth 5.53%
FCF growth 10.89%
Profitability
61 /100
Moderate
Gross margin 31.02%
Net margin 6.05%
Op. margin 15.06%
Quality
59 /100
Average
ROIC 11.18%
ROA 4.79%
Asset turnover 0.79x
Debt
44 /100
Moderate
Current ratio 1.47x
Int. coverage 3.67x
Net debt/EBITDA 3.66x
Stability
90 /100
Stable
Beta 0.87x
Rev. volatility 0.95%
EPS volatility 29.03%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o DVA
Online

O podjetju

DaVita Inc. is an American company specializing in providing dialysis services and managing nephrology centers. The company is headquartered in Denver, Colorado, and is one of the leading providers of dialysis care in the United States and other countries. Its services include dialysis in hospitals, independent dialysis centers, and home dialysis.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Care Facilities

CEO

Javier J. Rodriguez

Employees

78,000

Headquarters

Denver

Prihajajoči dogodki

28 OKT.

Earnings

Upcoming earnings report

46d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.